Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 4 1Phase 3 1

Status

Completed 4Withdrawn 2

Sponsor Class

OTHER 14INDUSTRY 6NIH 1NETWORK 1

Study Type

Interventional 6

Sponsor

Conditions

Vomiting 6Neoplasms 3Nausea 3Solid Tumours 1Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1

Interventions

Dexamethasone 11Palonosetron 9casopitant 6Ondansetron 6Granisetron 6Aprepitant 5netupitant, palosentron drug combination 3Duration of Therapy 2netupitant 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1alizapride 1Tropisetron 1Tablets 1NDC80 protein, human 1Metoclopramide 1Injections, Intravenous 1Exercise 1Dronabinol 1Docetaxel 1Cyclophosphamide 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Vomiting × Granisetron × Clear all
NCT00343460 2026-03-02

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Heron Therapeutics

Phase 3 Completed
1,428 enrolled 21 charts

Nausea, Vomiting

NCT01596413 2024-07-26

Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

Kyowa Kirin Co., Ltd.

Phase 1 Withdrawn

Vomiting

NCT01596426 2024-07-26

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Kyowa Kirin Co., Ltd.

Phase 1 Withdrawn

Vomiting

NCT01596400 2024-06-17

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Kyowa Kirin Co., Ltd.

Phase 1 Completed
19 enrolled

Vomiting

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed
494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed
50 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡